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Introduction
Osteoporosis has become one of the most important
public health problems due to fractures and their medical
and economic consequences for aging individuals and
society. Since osteoporosis can be influenced by
hormonal status, dietary habits, lifestyle, and hereditary
factors, it seems relevant to study the impact of these
factors on bone mineral density (BMD) and bone
turnover [1–3].
Genetic factors are involved in determining BMD
and in the pathogenesis of osteoporosis. These are
important in the peak bone mass attained and can
impact bone turnover. Twin and family studies suggest
that up to 85% of the variance in BMD could be
genetically determined [4–6]. Other important factors
are physical activity and hormonal and nutritional
influences [3–7].
Several common allelic variants have been identified
in the vitamin D receptor (VDR) gene. BsmI restriction
fragment length polymorphisms (RFLPs) may be found
in the non-coding region of the VDR gene in the intron
separating exons 8 and 9. VDR gene polymorphism has
been associated with peak bone mass [8] and higher
rates of bone turnover [9] in adults and intestinal
calcium absorption and BMD in growing children [10].
However, other studies have shown no association
between VDR, ER and/or COLIA 1 gene polymorphisms
and BMD or bone turnover [9,11–13].
SUMMARY
Objective: Genetic factors are involved in determining bone mineral density (BMD) and in the pathogenesis
of osteoporosis. There are relationships between various genetic polymorphisms and BMD or bone turnover.
The aim of our study was to assess polymorphisms in the vitamin D receptor (VDR) gene (BsmI) in relation
to BMD and bone turnover in a group of Polish postmenopausal women from the Lower Silesia region.
Materials and Methods: BMD at the lumbar spine and proximal femur, bone turnover (osteocalcin and
carboxyterminal cross-linked telopeptide of type I collagen, ICTP), and restriction fragment length polymorphism
(RFLP) of the VDR gene using the BsmI restriction enzyme were examined in 116 postmenopausal women.
Results: Despite the fact that we failed to detect statistically significant differences between the VDR genotypes
in BMD, a trend towards higher BMD in women carrying allele b compared with wild-type subjects in our
study is similar to previous reports. We also observed a higher allele b frequency in the control group (normal
bone mass) compared with osteopenic/osteoporotic women (59.1% vs 40.0%). The lower activity of the
resorption marker ICTP seen in allele b carriers could be involved.
Conclusion: We report an association between VDR gene polymorphism and decreased BMD in Polish
postmenopausal women from the Lower Silesia region, but this requires further robust studies for confirmation.
[Taiwanese J Obstet Gynecol 2005;44(1):57–61]
Key Words: BMD, bone turnover, osteoporosis, VDR gene polymorphisms
■  ORIGINAL ARTICLE  ■
˙ ´ ´
M. Demissie, et al
Taiwanese J Obstet Gynecol • March 2005 • Vol 44 • No 158
The aim of our study was to assess polymorphisms
of the VDR gene in relation to BMD and bone turnover
in a group of Polish postmenopausal women.
Materials and Methods
Subjects
We recruited by advertisement a group of healthy
postmenopausal women who had not used hormone
replacement therapy at any time. Menopause was
defined as lack of menstrual bleeding for longer than 2
years. The study protocol was approved by the local
ethics committee. All subjects gave their informed
consent.
Analysis of the VDR gene polymorphism
VDR gene polymorphism (BsmI) was explored using
polymerase chain reaction (PCR)-RFLP. Genomic DNA
was obtained from human leukocyte nuclei isolated
from whole blood. PCR products were digested using
the restriction enzyme BsmI and then separated by
polyacrylamide gel electrophoresis. The allele without
the restriction site was designated the B allele and the
allele with this restriction enzyme site was designated
the b allele.
Bone mineral density
Densitometry of the lumbar spine (L2–L4) and proximal
femur including the femoral neck, trochanter major,
and Ward’s triangle was carried out using dual-energy
X-ray absorptiometry (DXA) with the Lunar DPX-plus
densitometer (Lunar Co, Madison, WI, USA). The co-
efficient of variation (CV%) for DXA measurements at
the four sites were 0.89%, 1.25%, 2.51%, and 2.82%,
respectively.
Bone turnover markers
Serum osteocalcin concentration was analyzed using
an immunoradiometric method (ELSA-OSTEO, CIS
Biointernational, ORIS Group, Gif-Sur-Yvette, France)
and carboxyterminal cross-linked telopeptide of type
I collagen (ICTP) concentrations were determined
using radioimmunoassay (Orion Diagnostica, Espoo,
Finland). Intra- and interassay CV% were 4.7% and
4.9% for ICTP and 3.8% and 4.5% for osteocalcin,
respectively.
Statistical analysis
Characteristics of the group variables are expressed as
the mean and standard deviation. Allelic frequencies
were estimated by gene counting, and genotype
distribution of the polymorphisms was tested against
the Hardy-Weinberg equilibrium by Chi-squared
analysis. Allelic frequencies were compared between
populations using Chi-squared analysis. Where appro-
priate, b allele homozygotes were combined with het-
erozygotes and the difference in clinical characteristics
with and without the b allele was compared using
the ANOVA test, adjusting for potential confounding
factors (age, height, weight, years since menopause,
tobacco smoking). All calculations were performed
using statistical software (version 4.5 win, StatSoft
Inc, Tulsa, OK, USA). The differences were statistically
significant at a p value of 0.05 or less. In one case,
borderline statistical significance of between 0.05 and
0.1 was reported.
Results
The study was carried out in 116 healthy postmenopausal
women aged 52.4 ( 5.1 years who were 4.7 ( 3.6 years
postmenopause. Most had a normal BMD at the ex-
amined sites (91 women), 20 women were osteopenic,
and only five were osteoporotic according to the World
Health Organization criteria. There were no differences
in age, height, weight, and body mass index between
these women (Table 1).
In order to compare clinical, biochemical, and genetic
data between the groups with normal and decreased
BMD, subjects with a normal BMD served as controls
for osteopenic and osteoporotic subjects. Similar BMD
values at various sites (expressed in T-score and Z-score)
confirmed appropriate subject qualification for the
groups with either normal or decreased BMD (Table 1).
PCR-RFLP revealed 19 wild type (homozygous BB)
subjects (16.3%), 66 heterozygous allele b carriers (Bb
genotype; 56.8%), and 31 homozygous allele b (bb
genotype) subjects (26.7%). The allelic frequency of the
b allele was calculated as 54.9%. Genotype distributions
did not differ from those expected under Hardy-Weinberg
equilibrium conditions (p = 0.14). In spite of the small
number of subjects in the study, we attempted to
compare allele b frequencies between subjects with a
normal BMD or osteopenia/osteoporosis. There was a
significantly lower frequency of VDR gene BsmI poly-
morphism in subjects with osteopenia and osteoporo-
sis compared with control subjects (59.1% vs 40.0%;
p = 0.005) (Table 1).
In a study of the influence of BsmI polymorphism on
BMD and other anthropometric and clinical parameters,
we found no statistically significant differences in age,
BMD, and bone turnover parameters between subgroups
with different VDR genotypes. Only bone resorption
marker ICTP activity showed lower values (at the bor-
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Table 1. Differences in clinical, biochemical, and genetic data between subjects with at least osteopenia
(T-score < –1.0 standard deviations) and those with normal bone mineral density (BMD; control group)
Control group Osteopenia/osteoporosis p
n 91 25
Age (yr) 52.9 ( 6.7 51.5 ( 3.7 0.1
Height (cm)  163.1 ( 8.40 162.0 ( 11.7 0.6
BMI (kg/m2) 29.3 ( 7.8 29.0 ( 8.9 0.4
Lumbar spine L2–L4
BMD (g/cm2)   1.307 ( 0.147   0.982 ( 0.117 0.000001
T-score   0.850 ( 1.259 –1.811 ( 0.971 0.000002
Z-score   0.843 ( 1.291 –1.070 ( 0.927 0.0003
Femoral neck
BMD (g/cm2)   0.995 ( 0.122   0.841 ( 0.089 0.001
T-score   0.128 ( 1.019 –1.155 ( 0.747 0.001
Z-score   0.265 ( 1.047 –0.403 ( 0.922 0.1
Ward’s triangle
BMD (g/cm2)   0.876 ( 0.148   0.707 ( 0.106 0.004
T-score   0.258 ( 1.143 –1.555 ( 0.820 0.004
Z-score –0.033 ( 1.172 –0.548 ( 0.853 0.1
Trochanter major
BMD (g/cm2)   0.849 ( 9.118   0.706 ( 0.072 0.002
T-score   0.544 ( 1.078 –0.760 ( 0.658 0.002
Z-score   0.466 ( 1.126 –0.391 ( 0.702 0.04
ICTP (ng/mL)   3.0 ( 1.2   2.1 ( 0.9 0.5
Osteocalcin (ng/mL) 18.6 ( 6.8 22.9 ( 3.8 0.1
Allelic frequency, f(b) 59.1% 40.0% 0.005
BMI = body mass index; ICTP = carboxyterminal cross-linked telopeptide of type I collagen.
derline of statistical significance) in subjects carrying
allele b compared with wild-type subjects (Table 2).
Discussion
The study was carried out in a group of Polish post-
menopausal women from the Lower Silesia region
as part of a larger study. Nutritional, metabolic, and
genetic aspects of the menopause related to obesity
in these women have been published recently [14].
A number of polymorphic variants in the VDR gene
have been identified and extensively studied in various
populations. Most reports on the genotype–phenotype
relationship in the VDR gene have focused on the BsmI
site. Data gathered so far show that allele b of the VDR
gene is more advantageous in terms of bone metabolism,
calcium homeostasis, bone accrual during childhood,
and bone preservation later in life; conversely, wild-type
BB subjects could be more likely to develop osteoporosis
[15].
In this preliminary report, the BsmI allelic frequency
(allele b frequency 0.54, bb genotype of 26.7%) was
higher than or similar to those observed in other
Caucasian populations [9,11–13], especially Slavic, and
in earlier Polish studies [16,17]. For example, in a meta-
analysis, the BsmI bb genotype frequency was 2% among
Asians, 5% among African-Americans, and 17% among
Caucasians [15].
The absence of the BsmI site has been associated
with a small-to-modest decrease in bone mass and a
twofold increase in the risk of hip fracture compared
with the presence of this site [15]. Thus, we tested all
clinical characteristics in our group against a dichoto-
mous value: presence or lack of BsmI polymorphism in
the VDR gene. Despite the fact that we failed to detect
statistically significant differences between the VDR
genotypes in BMD, a trend towards better bone
parameters in women carrying allele b compared with
those carrying the BB wild type in our study is similar to
that in previous reports. It could also be confirmed by
the higher allele b frequency in the control group (normal
bone mass) compared with osteopenic/osteoporotic
women. Conceivably, lower activity of the resorption
marker ICTP in allele b carriers (at the borderline of
statistical significance) could be one factor involved,
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but this requires further more robust studies.
The incidence of osteoporosis and osteopenia was
quite low in our group of postmenopausal women
compared with other populations, but this was in
agreement with our previous observations [17,18]. It
seems to reflect the real BMD distribution in the Polish
postmenopausal population of Lower Silesia.
A very recent study summarizing various gene
polymorphisms involved in osteoporosis and fracture
occurrence has indicated associations of a single
nucleotide polymorphism and BMD and emphasizes
the importance of using ethnically homogenous
populations in such epidemiologic studies [19]. Our
group, being the offspring of families of various descent
from other parts of central and eastern Poland, could
not fulfill this criterion. However, our data seem to be
interesting and potentially important, so we decided to
continue this study.
The discrepancies with earlier studies may be ex-
plained not only by the differences in genetic back-
ground of the populations studied but, alternatively,
environmental–lifestyle factors or gene–environmental/
gene–nutrient interaction (e.g. calcium intake), as pre-
viously suggested for this polymorphism, could be
involved.
We can confirm an association between VDR gene
polymorphism and a decreased BMD in Polish post-
menopausal women from Lower Silesia, but further
more robust studies are required.
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